The novel GSDMD inhibitor GI‐Y2 exerts antipyroptotic effects to reduce atherosclerosis
Abstract Introduction Gasdermin D (GSDMD) and the pyroptosis it mediates are importantly involved in cardiovascular diseases (CVDs). Identifying and developing new inhibitors of GSDMD could be a promising strategy for treating pyroptosis‐mediated diseases, such as atherosclerosis. Objectives We aime...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley
2025-03-01
|
| Sarja: | Clinical and Translational Medicine |
| Aiheet: | |
| Linkit: | https://doi.org/10.1002/ctm2.70263 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|